Akseli Hemminki

Also affiliated with Helsinki University Hospital, Gene Therapy Laboratory, Integrated BioTherapeutics (United States), Biocenter Finland, Cancer Society of Finland

Biochemistry, Genetics and Molecular BiologyMedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs”.

Treatment with anti-HER2 chimeric antigen receptor tumor-infiltrating lymphocytes (CAR-TILs) is safe and associated with antitumor efficacy in mice and companion dogs

Työväentutkimus Vuosikirja(2022)10.1101/2022.09.11.507449

N/A

0DataRank · unranked

1 citations

Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher +7 more

Treatment with Anti-HER2 Chimeric Antigen Receptor Tumor-Infiltrating Lymphocytes (CAR-TILs) Is Safe and Associated with Antitumor Efficacy in Mice and Companion Dogs

Cancers(2023)10.3390/cancers15030648

N/A

0DataRank · unranked

25 citations

Rebecca Riise, Sara Saellström, Joakim Karlsson, Samuel Alsén, Valentina Bucher +7 more